Introduction: The Trade-Off Nobody Warns You About

Here’s a scenario that plays out in men’s health clinics every day: a man in his early 30s has symptoms of low testosterone. He’s fatigued, his libido is low, he’s gaining weight. He gets bloodwork, confirms his T is low, and starts testosterone replacement therapy. He feels great.

Two years later, he and his partner start trying to have a baby. A semen analysis reveals his sperm count is near zero. He’s now facing months or years of recovery — and the possibility that his fertility may never fully return to pre-TRT levels.

This scenario is entirely preventable. The problem isn’t that TRT is dangerous — it’s that most TRT protocols ignore fertility preservation from the start. Luvo’s testosterone program is built differently, offering a range of approaches that let men optimize testosterone and protect reproductive function simultaneously.

Why Exogenous Testosterone Suppresses Fertility

Understanding the mechanism is critical for making informed treatment decisions.

Your hormonal system operates on feedback loops. The hypothalamus produces GnRH, which tells the pituitary to produce LH and FSH. LH stimulates the testes to produce testosterone. FSH stimulates the testes to produce sperm. When testosterone levels are sufficient, the hypothalamus reduces GnRH output, completing the feedback loop.

When you introduce exogenous testosterone, blood levels rise quickly to the target range. The hypothalamus detects this and dramatically reduces GnRH output. The pituitary, receiving little GnRH, stops producing meaningful amounts of LH and FSH. Without FSH, the Sertoli cells in the testes that support sperm development lose their stimulation. Sperm production can decline by 90% or more.

This isn’t a rare side effect — it’s the expected physiological response. It happens to virtually every man on TRT who doesn’t take steps to prevent it.

Option 1: Enclomiphene as a Standalone Approach

For men whose primary concern is preserving fertility while addressing low testosterone, Enclomiphene offers an elegant solution. By blocking estrogen feedback at the hypothalamus, Enclomiphene increases GnRH, LH, and FSH — stimulating both testosterone and sperm production simultaneously.

This approach is particularly attractive for men in their 20s and 30s who are actively trying to conceive or expect to in the near future, men with mild-to-moderate testosterone deficiency who may respond well to enhanced endogenous production, and men who want to try the most conservative approach first.

The limitation of Enclomiphene is that the degree of testosterone elevation may be less than what TRT provides. Men with very low baseline testosterone or primary testicular failure may not achieve sufficient improvement with Enclomiphene alone.

Luvo’s providers evaluate each man’s hormonal profile to determine whether Enclomiphene alone is likely to provide adequate testosterone optimization.

Option 2: TRT Plus Gonadorelin

For men who need the more robust testosterone elevation that TRT provides but still want to protect fertility, the combination of testosterone medication and Gonadorelin is Luvo’s recommended approach.

TRT raises testosterone levels reliably and substantially, delivering the full range of symptomatic benefits. Gonadorelin, administered alongside TRT, replaces the GnRH signal that exogenous testosterone suppresses. This keeps the pituitary producing LH and FSH, maintaining testicular function and sperm production even in the presence of exogenous testosterone.

This combination provides the best of both worlds: optimal testosterone levels for symptom relief and quality of life, plus preserved reproductive capacity. It’s a protocol that requires more clinical sophistication to manage, which is why it’s not commonly offered by high-volume telehealth competitors that prioritize simplicity over optimization.

Option 3: The Comprehensive Triple Protocol

Some patients benefit from all three medications working together. In this approach, TRT provides the primary testosterone elevation. Gonadorelin maintains pituitary and testicular function. Enclomiphene provides additional endogenous stimulation and helps manage estrogen-related effects.

This triple protocol is the most comprehensive option in Luvo’s testosterone program and represents a level of hormonal optimization that few telehealth platforms offer. It’s typically reserved for men who want maximum testosterone optimization, need robust fertility preservation, benefit from the estrogen-modulating effects of Enclomiphene, and are comfortable with a multi-medication protocol.

Your Luvo provider will recommend the approach that best matches your hormonal profile, symptoms, and life goals — and will adjust the protocol over time as your needs evolve.

Explore Luvo’s testosterone medication, Enclomiphene, and Gonadorelin options, or visit the full testosterone program page.